Risk of resistance related to antibiotic use before admission in patients with community-acquired bacteraemia

被引:31
作者
Pedersen, G [1 ]
Schonheyder, HC
Steffensen, FH
Sorensen, HT
机构
[1] Aalborg Hosp, Dept Med M, Aalborg, Denmark
[2] Aalborg Hosp, Dept Clin Microbiol, Aalborg, Denmark
[3] Univ Aarhus, Danish Epidemiol Sci Ctr, Dept Epidemiol & Social Med, Aarhus, Denmark
[4] Aarhus Univ Hosp, Dept Med 5, Aarhus, Denmark
关键词
D O I
10.1093/jac/43.1.119
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We analysed the association of antibiotic therapy before admission and antibiotic resistance of blood isolates in a total of 1717 community-acquired bacteraemias in the County of Northern Jutland during 1992-96. Antibiotics had been prescribed to 14% of the patients during the 30 days before admission and to 37% during the 6 months. The most frequently prescribed antibiotics within 30 days were ampicillin (28%), penicillin G (27%), sulphonamides and/or trimethoprim (16%) and macrolides (14%). The most frequent blood isolates were Escherichia coli (33%), other Enterobacteriaceae (8%), Streptococcus pneumoniae (23%) and Staphylococcus aureus (10%). Of the 575 isolates of E. coli, 425 (74%), 432 (75%) and 518 (90%) were susceptible to ampicillin, sulphonamides and trimethoprim, respectively. Previous antibiotic prescriptions were strongly associated with resistance to ampicillin, sulphonamides and trimethoprim in E. coli. The association was less pronounced for S. aureus and enteric rods other than E. coli. Antibiotic prescriptions within the last 3 months predicted antibiotic resistance, and this should be taken into account when selecting empirical antibiotic therapy of severe community-acquired infections.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 21 条
[1]   BETA-LACTAM RESISTANCE AMONG ESCHERICHIA-COLI AND KLEBSIELLA SPECIES BLOOD CULTURE ISOLATES IN FINNISH HOSPITALS [J].
ARSTILA, T ;
AUVINEN, H ;
HUOVINEN, P ;
AHONEN, E ;
BRANDER, M ;
EEROLA, E ;
ESKOLA, J ;
HAKKARAINEN, K ;
HERVA, E ;
HIRVAS, L ;
HIRVONEN, P ;
JAGERROOS, H ;
JARVINEN, H ;
KATILA, ML ;
KLOSSNER, ML ;
KONTIAINEN, S ;
KORPELA, J ;
KOSKELA, M ;
KOSTIALATHOMPSON, A ;
KARKKAINEN, P ;
LARINKARI, U ;
LEHTONEN, OP ;
LIIMATAINEN, O ;
NISSINEN, A ;
OINONEN, S ;
RENKONEN, OV ;
RUUSKA, P ;
SARKKINEN, H ;
VIKBERG, V .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 (06) :468-474
[2]  
Balows A., 1991, MANUAL CLIN MICROBIO
[3]  
Casals JB, 1991, ANTIBACTERIAL ANTIFU
[4]   PREVALENCE AND ANTIBIOTIC-SENSITIVITY OF DANISH VERSUS OTHER EUROPEAN BACTERIAL ISOLATES FROM INTENSIVE-CARE AND HEMATOLOGY-ONCOLOGY UNITS [J].
FOMSGAARD, A ;
HOIBY, N ;
FRIIS, HM ;
GAHRNHANSEN, B ;
KOLMOS, HJJ ;
SCHOUENBORG, P ;
KORSAGER, B ;
TVEDE, M ;
GUTSCHIK, E ;
BREMMELGAARD, A .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (04) :275-281
[5]   CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].
GARNER, JS ;
JARVIS, WR ;
EMORI, TG ;
HORAN, TC ;
HUGHES, JM .
AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140
[6]   EVALUATION OF 2 BBL CRYSTAL SYSTEMS FOR IDENTIFICATION OF SOME CLINICALLY IMPORTANT GRAM-NEGATIVE BACTERIA [J].
HOLMES, B ;
COSTAS, M ;
THAKER, T ;
STEVENS, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (09) :2221-2224
[7]  
Hosmer D., 1989, Applied Logistic Regression, V1st, DOI DOI 10.1097/00019514-200604000-00003
[8]   Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci [J].
Kristinsson, KG .
MICROBIAL DRUG RESISTANCE, 1997, 3 (02) :117-123
[9]   RESISTANCE TO ANTIMICROBIAL DRUGS - A WORLDWIDE CALAMITY [J].
KUNIN, CM .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (07) :557-561